CorMedix Inc.CRMDNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P0
Near historical low
vs 5Y Ago
-75.9x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-199.70%
Q3 2025130.59%
Q2 202512.15%
Q1 2025-7.84%
Q4 202415.32%
Q3 2024-10.81%
Q2 2024-0.68%
Q1 202412.92%
Q4 202371.92%
Q3 202311.39%
Q2 2023-7.95%
Q1 202335.60%
Q4 202220.47%
Q3 2022-8.39%
Q2 20226.34%
Q1 20224.34%
Q4 202118.67%
Q3 202114.33%
Q2 2021-27.07%
Q1 202121.44%
Q4 20202.63%
Q3 202014.20%
Q2 20202.13%
Q1 202018.18%
Q4 20191.79%
Q3 20192.31%
Q2 201929.56%
Q1 2019-10.32%
Q4 20189.99%
Q3 20183.42%
Q2 20182.25%
Q1 2018-3.32%
Q4 2017-1.19%
Q3 2017-2.87%
Q2 2017-22.33%
Q1 20178.52%
Q4 20164.98%
Q3 201617.75%
Q2 2016-8.99%
Q1 2016216.50%